Skip to main content
. 2012 Jun 1;2(6):707–720. doi: 10.1534/g3.112.001990

Table 4. Descriptive statistics of LG, including the position, 95% CI, LOD score, PVE, associated P value, and specific additive and dominance effects of each QTL linked to every phenotype related to growth.

Phenotypea LG Position, cM 95% CI, cM LOD % PVE P Value, χ2 P Value, F Additive Effect SE Dominance Effect SE Nearest Marker
Weight T4, g 1 70.5 70-83 4.742 4.477 0.032 0.105 19.696 0.2342 29.897 0.1300 OMM-1195
3 44.8 20-48 4.945 3.255 0.009 0.046 22.488 0.2365 25.514 0.0845 OMM-5007
4 43.0 39-47 7.438 5.386 0 0.005 28.711 0.8577 12.158 0.4404 OMM5155i
5 26.7 21-28 5.267 8.826 0.197 0.352 10.377 0.1783 14.236 0.0952 CA-378164
9 40.2 39-43 5.137 4.009 0.303 0.468 23.987 0.1054 34.588 0.2607 SSA-0072BSFU
12 78.4 73-78.4 8.803 6.783 0.203 0.359 3.5396 0.0340 −40.241 0.0346 OMM-5060
22 17.1 14-19 5.137 5.841 0.087 0.204 44.324 0.2342 5.8255 0.1300 OMM-3015i
24 11.9 41-94 8.583 6.433 0.162 0.309 8.9338 0.2365 31.112 0.0845 OMM-1201
27 0.0 0-6 5.858 6.027 0.003 0.02 20.090 0.8577 19.243 0.4404 OMM-5102ii
31 0.0 0-5 7.293 4.866 0.083 0.199 −4.786 0.1783 12.887 0.0952 C129
34 0.0 0-12 5.185 5.521 0.142 0.283 9.2407 0.1054 23.328 0.2607 BX319411i
40 52.4 46-90 5.633 4.745 0.021 0.079 17.955 0.0340 −0.681 0.0346 BX-079862
Specific growth rate, T1–T3, % day-1 12 78.4 76-78.4 4.276 4.669 0.036 0.051 −0.016 0.2365 0.2152 0.0845 OMM-5060
20 0.0 0-37 4.405 3.984 0.041 0.057 0.0519 0.8577 0.1643 0.4404 OMM1210
22 17.1 0-17 3.227 5.515 0.048 0.056 −0.306 0.1783 −0.089 0.0952 OMM-3015i
34 0.0 0-5 3.605 4.474 0.042 0.051 −0.166 0.1054 −0.151 0.2607 BX319411i
Specific growth rate, T1–T4, % day-1 1 70.5 70-74.5 14.275 4.587 0 0.009 −0.171 0.0340 −0.158 0.0346 OMM-1195
2 78.2 78-115 8.016 4.119 0 0.022 0.1342 0.2342 0.0340 0.1300 OMY-RGT2TUFii
3 44.8 10-46 8.509 3.083 0 0.003 −0.121 0.0371 −0.112 0.0481 OMM-5007
9 40.2 39-42 10.781 5.022 0.028 0.019 −0.175 0.0371 −0.128 0.0370 SSA-0072BSFU
12 78.4 76-78.4 11.862 4.628 0.003 0.049 −0.039 0.1488 0.1737 0.0532 OMM-5060
14 45.9 36-47 6.128 9.376 0.039 0.225 0.1685 0.1574 0.0419 0.0829 OMI-30TUFi
20 0.0 0-38 10.361 3.449 0 0.012 0.0416 0.5659 0.1424 0.2905 OMM1210
22 17.1 0-17.1 9.466 3.468 0.005 0.08 −0.216 0.1228 −0.079 0.0656 OMM-3015i
23 13.1 9-25 8.034 5.03 0.027 0.018 0.1479 0.1771 0.1234 0.0891 BHMS-238
24 11.9 9-13.5 13.409 4.148 0 0.021 −0.016 0.0343 −0.175 0.0334 OMM-1201
31 42.4 36-42.4 13.392 4.122 0.019 0.015 0.1125 0.3519 0.0904 0.4061 sf004732_01CG
34 0.0 0-5 12.315 4.175 0 0.02 −0.109 0.0753 −0.085 0.1861 BX319411i
Size T4, mm 3 49.2 45-49.2 11.915 5.067 0.027 0.035 8.904 1.7452 4.320 0.8313 sf000071_02CT
4 32.7 34-50 13.65 4.618 0.036 0.048 4.422 0.5432 −0.093 0.0803 sf003084_01AG
12 78.4 52-78.4 14.042 6.148 0.024 0.041 0.3066 1.7646 −1.215 0.6311 OMM-5060
20 0.0 0-66 12.296 5.012 0.049 0.042 −1.032 0.8970 −0.89 0.2640 OMM1210
22 20.6 0-20.6 12.262 6.302 0.045 0.038 10.499 4.1333 3.6166 1.4460 sf004055_02CT
24 1.5 0-6 15.655 4.703 0.047 0.046 6.2293 2.3095 1.7749 1.2464 sf003334_01CT
26 11.4 8-14 12.8 3.657 0.045 0.043 0.0000 0.094 8.8897 3.7901 sf003018_09CT
38 28.5 25-29.5 13.278 6.273 0.023 0.031 −1.209 0.8342 −0.576 0.5330 OMM1345
Fulton’s condition factor T4 24 49.3 21-49.3 3.018 4.359 0.036 0.053 3.1857 8.3655 2.0000 2.1284 sf003442_01CG
38 0.0 0-11 3.57 8.214 0.027 0.035 0.1998 0.4860 0.3300 0.7019 OMY21INRAiii
Liver fresh weight T3, mg 11 0.0 0-11 6.752 9.037 0.006 0.036 −0.893 0.5955 −0.803 0.3896 BX-870052i
15 52.6 48-52.6 5.698 5.24 0 0.002 −1.024 4.0172 −0.419 2.0618 sf004811_AT
20 58.1 30-59 9.649 5.99 0 0.001 0.9517 0.3583 1.2504 0.3946 CA-376300i
22 16.3 12-17 7.517 9.788 0.047 0.053 1.6254 1.2706 0.0679 0.8132 OMM-5147
24 11.9 8-16 9.996 4.01 0.006 0.037 0.4826 0.0568 1.3452 0.0945 BHMS-238
34 0.0 0-9 5.595 6.965 0.006 0.039 0.3635 0.3583 0.4824 0.1946 BX319411i
40 52.4 49-105 9.808 7.119 0.031 0.051 −0.595 1.2706 0.2837 0.0132 SFO-226
Hematocrit T3, % of red blood cells 4 10 5-45 3.337 17.279 0.002 0.002 15.473 4.4098 4.3119 2.2291 OMM-1220
Plasma chloride T3, mmol L-1 7 36.6 19-36.6 4.428 5.066 0.045 0.051 0.5712 0.6385 0.2201 0.9368 OMM-5312i
Plasma osmolality T3, mmol kg-1 10 42 35-46 3.814 9.257 0.039 0.046 −3.019 0.6014 −4.342 0.4977 SAL5UoG
Plasma glucose T3, mg mL-1 10 26 12-62 3.241 11.432 0.016 0.02 14.754 2.3124 −1.468 1.2598 sf004715_AC
Hepatic glycogen T3, mg g liver-1 2 40.2 20-77 9.48 4.495 0.029 0.04 9.0189 4.3652 4.8747 2.4390 sf004818_06CT
36 0.0 0-21.5 5.149 10.576 0.017 0.022 8.9957 1.7665 4.3860 1.7135 sf004038_AG
ghr mRNA level T3 40 66 30-95 4.401 12.479 0.032 0.043 −16.17 0.4591 −13.82 0.9399 BX-079862
igf1 mRNA level T3 3 8.1 5-18 3.391 15.612 0.001 0.002 38.289 1.6790 14.576 0.8526 sf004560_GT
igf1r mRNA level T3 3 10.1 5-68 3.178 13.362 0.035 0.047 41.485 0.5037 9.7899 0.3448 OMM5008
Hepato-somatic Index T3 2 112.4 105-117 8.503 5.88 0.019 0.044 0.9172 0.2425 0.4344 0.3797 BX-318599
3 44.8 12-48 6.31 4.443 0.007 0.027 1.2470 0.1765 0.8431 0.2290 OMM-5007
4 43.0 32-44 13.266 4.454 0.005 0.045 1.1688 0.2144 1.0091 8.2750 OMM5155i
5 26.7 23-38 11.077 4.866 0.004 0.09 −0.275 0.1639 0.6595 0.1752 CA-378164
7 13.7 10-46 4.624 4.387 0 0.003 0.9594 0.2867 −0.025 0.5421 OMM-1263
20 58.1 20-58.1 15.991 4.948 0.004 0.049 0.9517 0.1440 1.2504 0.1586 CA-376300i
22 17.1 14-17.1 13.496 6.774 0.002 0.063 2.1143 0.6137 0.2365 0.3277 OMM-3015i
23 13.1 2-13.1 10.931 4.985 0 0.03 −1.252 0.7850 −0.535 0.3950 BHMS-238
38 28.5 24-29 14.168 4.007 0.026 0.021 0.3635 0.3590 0.4824 0.2296 OMM1345

Sign (-/+) of the dominance and additive effect indicates to the parent whose allele increases the phenotypic values of the studied trait in the progeny. LG, linkage age; CI, confidence interval; LOD, log10 of the odd ratio; PVE, percent variance explained; QTL, quantitative trait loci; SE: standard error of the mean; T4, November; T1, May; T3, August; ghr, growth hormone receptor; igf1, insulin growth factor-1; igf1r, insulin growth factor-1 receptor.

a

For each phenotype, the sampling period was added (T1, T3, T4) and the unit of measure is given in parentheses.